首页> 外文期刊>Pneumonia. >Acute fibrinous and organising pneumonia following lung transplantation is associated with severe allograft dysfunction and poor outcome: a case series
【24h】

Acute fibrinous and organising pneumonia following lung transplantation is associated with severe allograft dysfunction and poor outcome: a case series

机译:肺移植后急性纤维化和组织性肺炎与严重的同种异体移植功能障碍和不良预后相关:一个病例系列

获取原文
获取外文期刊封面目录资料

摘要

Acute fibrinous and organising pneumonia (AFOP) is a histopathologic variant of acute lung injury that has been associated with infection and inflammatory disorders and has been reported as a complication of lung transplantation. A retrospective chart review was performed for all patients transplanted at the University of Wisconsin Hospital and Clinics from January 1995 to December 2013 ( n = 561). We identified 6 recipients whose clinical course was complicated by AFOP. All recipients were found to have AFOP on lung biopsy or at post-mortem examination, and 5 of the 6 patients suffered progressive allograft dysfunction that led to fatal outcome. Only 1 of the 6 patients stabilised with augmented immunosuppression and had subsequent improvement and stabilisation of allograft function. We could not clearly identify any specific cause of AFOP, such as drug toxicity or infection. Lung transplantation can be complicated by lung injury with an AFOP pattern on histopathologic examination of lung biopsy specimens. The presence of an AFOP pattern was associated with irreversible decline in lung function that was refractory to therapeutic interventions in 5 of our 6 cases and was associated with severe allograft dysfunction and death in these 5 individuals. AFOP should be considered as a potential diagnosis when lung transplant recipients develop progressive decline in lung function that is consistent with a clinical diagnosis of chronic lung allograft dysfunction.
机译:急性纤维化和组织性肺炎(AFOP)是急性肺损伤的组织病理学变异,已与感染和炎性疾病相关,并已报道为肺移植的并发症。对1995年1月至2013年12月在威斯康星大学医院和诊所移植的所有患者进行回顾性图表回顾(n = 561)。我们确定了6名接受者,其临床过程因AFOP而变得复杂。发现所有接受者在肺活检或验尸时均患有AFOP,6例患者中有5例患有进行性同种异体移植功能障碍,导致致命后果。 6例患者中只有1例通过增强的免疫抑制而稳定下来,随后具有同种异体移植功能的改善和稳定。我们无法清楚地确定AFOP的任何特定原因,例如药物毒性或感染。在肺活检标本的组织病理学检查中,肺损伤可伴有AFOP模式的肺损伤。 AFOP模式的存在与肺功能的不可逆下降有关,在我们的6例患者中有5例因治疗干预而难治,并且与这5例患者的严重同种异体移植功能障碍和死亡有关。当肺移植受者出现肺功能进行性下降,这与慢性同种异体移植功能障碍的临床诊断一致时,应将AFOP视为潜在诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号